Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3-Reference-Cited by-同舟云学术

Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3

Published:2023-01 Issue: Volume:138 Page:102288
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Ochsner Urs A.^ORCID,De Groote Mary A.,Jarvis Thale C.,Liu Hang,Youmans Tessa,Hoang Teresa,Ribble Wendy,Day Joshua,Li Wei,Pearce Camron,Walz Amanda,Panthi Chandra M.,Rimal Binayak,Stevens Casey M.,Zgurskaya Helen I.,Jackson Mary,Ordway Diane,Gonzalez-Juarrero Mercedes,Sun Xicheng,Lamichhane Gyanu,Mason Clifford

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference74 articles.

1. The burden of pulmonary nontuberculous mycobacterial disease in the United States;Strollo;Ann Am Thorac Soc,2015

2. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. Managed Care health plan, 2008-2015;Winthrop;Ann Am Thorac Soc,2020

3. General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus;To;J Clin Med,2020

4. Advancing translational science for pulmonary nontuberculous mycobacterial infections. A road map for research;Daniel-Wayman;Am J Respir Crit Care Med,2019

5. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries;Adjemian;Am J Respir Crit Care Med,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations;Tuberculosis;2024-07

2. Nitric oxide-releasing prodrug for the treatment of complex Mycobacterium abscessus infections;Antimicrobial Agents and Chemotherapy;2024-02-07

3. New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway;Expert Review of Anti-infective Therapy;2023-06-23

4. Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infections;Expert Opinion on Drug Discovery;2023-06-04